TG Therapeutics, Inc. (TGTX)
USD 34.75
(-6.96%)
USD 34.75
(-6.96%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 219.1 Million USD | 8594.76% |
| 2022 | 2.52 Million USD | -57.28% |
| 2021 | 5.89 Million USD | 2757.21% |
| 2020 | -222 Thousand USD | -70.77% |
| 2019 | -130 Thousand USD | -303.13% |
| 2018 | 64 Thousand USD | -8.61% |
| 2017 | 70.02 Thousand USD | -21.69% |
| 2016 | 89.42 Thousand USD | -41.32% |
| 2015 | 152.38 Thousand USD | 0.0% |
| 2014 | 152.38 Thousand USD | 0.0% |
| 2013 | 152.38 Thousand USD | 699.98% |
| 2012 | 19.04 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | -100.0% |
| 2002 | 500 Thousand USD | -20.55% |
| 2001 | 629.35 Thousand USD | -51.57% |
| 2000 | 1.29 Million USD | 224.9% |
| 1999 | 400 Thousand USD | -87.5% |
| 1998 | 3.2 Million USD | 1500.0% |
| 1997 | 200 Thousand USD | 100.0% |
| 1996 | 100 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 65.09 Million USD | 12.32% |
| 2024 Q3 | 74.53 Million USD | 14.52% |
| 2024 Q1 | 57.95 Million USD | 60.86% |
| 2023 Q1 | 6.94 Million USD | 8920.78% |
| 2023 Q3 | 162.3 Million USD | 1045.99% |
| 2023 Q4 | 36.02 Million USD | -77.8% |
| 2023 FY | 219.1 Million USD | 8594.76% |
| 2023 Q2 | 14.16 Million USD | 103.9% |
| 2022 FY | 2.52 Million USD | -57.28% |
| 2022 Q4 | 77 Thousand USD | -16.3% |
| 2022 Q1 | 1.77 Million USD | -15.73% |
| 2022 Q2 | 571 Thousand USD | -67.9% |
| 2022 Q3 | 92 Thousand USD | -83.89% |
| 2021 Q1 | 654 Thousand USD | 100.24% |
| 2021 Q2 | 1.39 Million USD | 113.61% |
| 2021 Q4 | 2.11 Million USD | 21.46% |
| 2021 Q3 | 1.73 Million USD | 24.41% |
| 2021 FY | 5.89 Million USD | 2757.21% |
| 2020 Q3 | 38 Thousand USD | 0.0% |
| 2020 Q1 | 38 Thousand USD | 100.02% |
| 2020 Q2 | 38 Thousand USD | 0.0% |
| 2020 Q4 | -273.55 Million USD | -719984.21% |
| 2020 FY | -222 Thousand USD | -70.77% |
| 2019 FY | -130 Thousand USD | -303.13% |
| 2019 Q4 | -169.01 Million USD | -444881.58% |
| 2019 Q3 | 38 Thousand USD | 0.0% |
| 2019 Q2 | 38 Thousand USD | 0.0% |
| 2019 Q1 | 38 Thousand USD | 0.0% |
| 2018 FY | 64 Thousand USD | -8.61% |
| 2018 Q3 | 38 Thousand USD | 0.0% |
| 2018 Q2 | 38 Thousand USD | 0.0% |
| 2018 Q1 | 38 Thousand USD | -0.25% |
| 2018 Q4 | 38 Thousand USD | 0.0% |
| 2017 Q4 | 38.09 Thousand USD | -0.0% |
| 2017 FY | 70.02 Thousand USD | -21.69% |
| 2017 Q1 | 38.09 Thousand USD | 100.0% |
| 2017 Q2 | 38.09 Thousand USD | 0.0% |
| 2017 Q3 | 38.09 Thousand USD | 0.0% |
| 2016 Q1 | 38.09 Thousand USD | 0.0% |
| 2016 Q2 | 38.09 Thousand USD | 0.0% |
| 2016 FY | 89.42 Thousand USD | -41.32% |
| 2016 Q3 | 38.09 Thousand USD | 0.0% |
| 2016 Q4 | -78.96 Billion USD | -207289815.21% |
| 2015 Q3 | 38.09 Thousand USD | 0.0% |
| 2015 Q1 | 38.09 Thousand USD | 100.07% |
| 2015 Q2 | 38.09 Thousand USD | 0.0% |
| 2015 Q4 | 38.09 Thousand USD | -0.0% |
| 2015 FY | 152.38 Thousand USD | 0.0% |
| 2014 Q2 | 38.09 Thousand USD | 0.0% |
| 2014 Q3 | 38.09 Thousand USD | 0.0% |
| 2014 Q4 | -55.68 Million USD | -146264.94% |
| 2014 FY | 152.38 Thousand USD | 0.0% |
| 2014 Q1 | 38.09 Thousand USD | 100.17% |
| 2013 Q4 | -22.92 Million USD | -60284.52% |
| 2013 Q1 | 38.09 Thousand USD | 100.14% |
| 2013 Q2 | 38.09 Thousand USD | 0.0% |
| 2013 Q3 | 38.09 Thousand USD | 0.0% |
| 2013 FY | 152.38 Thousand USD | 699.98% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | -26.87 Million USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | 19.04 Thousand USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 100.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q4 | -85.06 Thousand USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | -100.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | 500 Thousand USD | -20.55% |
| 2002 Q3 | - USD | -100.0% |
| 2002 Q2 | 500 Thousand USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2001 Q2 | -295.31 Thousand USD | -145.0% |
| 2001 Q3 | - USD | 100.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | 629.35 Thousand USD | -51.57% |
| 2001 Q1 | 656.29 Thousand USD | 19.09% |
| 2000 Q1 | 211.26 Thousand USD | 5.63% |
| 2000 Q4 | 551.1 Thousand USD | 136.18% |
| 2000 Q2 | 303.89 Thousand USD | 43.85% |
| 2000 Q3 | 233.34 Thousand USD | -23.22% |
| 2000 FY | 1.29 Million USD | 224.9% |
| 1999 Q3 | 100 Thousand USD | 0.0% |
| 1999 FY | 400 Thousand USD | -87.5% |
| 1999 Q4 | 200 Thousand USD | 100.0% |
| 1999 Q1 | 100 Thousand USD | -83.33% |
| 1999 Q2 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | -96.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1998 FY | 3.2 Million USD | 1500.0% |
| 1998 Q4 | 600 Thousand USD | 500.0% |
| 1998 Q2 | 2.5 Million USD | 2400.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 FY | 200 Thousand USD | 100.0% |
| 1997 Q2 | 100 Thousand USD | 0.0% |
| 1997 Q1 | 100 Thousand USD | 0.0% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q4 | - USD | -100.0% |
| 1996 FY | 100 Thousand USD | 0.0% |
| 1996 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -476.221% |
| Alkermes plc | 1.37 Billion USD | 84.061% |
| Agenus Inc. | 139.61 Million USD | -56.937% |
| Aptorum Group Limited | -1.11 Million USD | 19756.442% |
| Ardelyx, Inc. | 106.66 Million USD | -105.425% |
| Dyadic International, Inc. | 922.95 Thousand USD | -23639.784% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -940.349% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 125416.999% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1740.294% |
| Novavax, Inc. | 639.93 Million USD | 65.761% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 567.79% |
| Pyxis Oncology, Inc. | -2 Million USD | 11055.4% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 42501.489% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1050.596% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 495954.078% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 41676.471% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 323.086% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -27220.2% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 267304.878% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -61.979% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -2683.738% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 326.001% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 85.565% |
| AlloVir, Inc. | -398 Thousand USD | 55152.261% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 8.984% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -51576.415% |
| Bicycle Therapeutics plc | -129.52 Million USD | 269.169% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -182490.0% |
| ChromaDex Corporation | 50.78 Million USD | -331.485% |
| Chimerix, Inc. | 324 Thousand USD | -67525.926% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 802.998% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 382.363% |
| CRISPR Therapeutics AG | 240.95 Million USD | 9.067% |
| Precision BioSciences, Inc. | 40.47 Million USD | -441.382% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 323.208% |
| Fortress Biotech, Inc. | 57.85 Million USD | -278.732% |
| Fortress Biotech, Inc. | 57.85 Million USD | -278.732% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -1221.759% |
| ImmuCell Corporation | 4.39 Million USD | -4883.936% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 306.466% |
| Immix Biopharma, Inc. | -5468.00 USD | 4007195.83% |
| Incyte Corporation | 3.44 Billion USD | 93.632% |
| Innoviva, Inc. | 261.06 Million USD | 16.071% |
| IO Biotech, Inc. | -756 Thousand USD | 29082.54% |
| Jaguar Health, Inc. | 7.72 Million USD | -2736.717% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 33098.193% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -82.967% |
| ContextLogic Inc. | 59 Million USD | -271.369% |
| MiMedx Group, Inc. | 266.84 Million USD | 17.889% |
| MEI Pharma, Inc. | 49.32 Million USD | -344.195% |
| NextCure, Inc. | -3.68 Million USD | 6047.557% |
| Onconetix, Inc. | -1.12 Million USD | 19538.858% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 856.379% |
| Opthea Limited | 21.72 Thousand USD | -1008684.53% |
| Psyence Biomedical Ltd. | -240.00 USD | 91295100.0% |
| Vaxcyte, Inc. | -75 Million USD | 392.144% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 382314.004% |
| Precigen, Inc. | 106 Thousand USD | -206605.66% |
| Pharming Group N.V. | 220.1 Million USD | 0.453% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -42445.243% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -21615.362% |
| PureTech Health plc | -1.6 Million USD | 13768.621% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -99.603% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 220.782% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 583.415% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1096.534% |
| Acelyrin, Inc. | -115 Thousand USD | 190628.696% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 2180062.193% |
| Summit Therapeutics Inc. | -2.05 Million USD | 10788.195% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 38472.68% |
| Senti Biosciences, Inc. | -2.68 Million USD | 8266.53% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -5308.739% |
| Elevation Oncology, Inc. | -39 Thousand USD | 561915.385% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 4666.653% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 5658.228% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -652.199% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -44075.0% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 398478.182% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -110.48% |
| Seer, Inc. | 7.02 Million USD | -3018.087% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -4904.751% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -916.978% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 185015.31% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 153000.538% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -35878.325% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -81.872% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 30.147% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 4382260.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -8412.354% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 431924.99% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -645.595% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 94543.103% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 44634.146% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 3186.898% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 46272.228% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 2106907.692% |
| Soligenix, Inc. | 97.31 Thousand USD | -225062.623% |
| Century Therapeutics, Inc. | -10.8 Million USD | 2127.089% |
| Kura Oncology, Inc. | -849 Thousand USD | 25907.774% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 426.52% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 149153.061% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -121.234% |
| Autolus Therapeutics plc | -4.86 Million USD | 4601.911% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -429.425% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 130521.429% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -131.314% |
| GRI Bio, Inc. | 10.84 Million USD | -1921.105% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -8526.347% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 2622.252% |
| IGM Biosciences, Inc. | -211.66 Million USD | 203.519% |
| INmune Bio, Inc. | 155 Thousand USD | -141260.0% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -253.748% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 14646.193% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 33889.29% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 748573.048% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -54404.478% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 11077.355% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 70102.556% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -131.956% |
| Verastem, Inc. | -62 Thousand USD | 353500.0% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -8898.275% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 84049.425% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -7138.454% |
| Histogen Inc. | 3.76 Million USD | -5713.425% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -37927.766% |
| Surrozen, Inc. | -27.23 Million USD | 904.657% |
| Organovo Holdings, Inc. | -5.38 Million USD | 4165.838% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 18285.047% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 954.322% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -992.699% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 11066160.606% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -3511.815% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 326488.703% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -41.551% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -150179.835% |
| Apollomics, Inc. | 127 Thousand USD | -172425.984% |
| Amarin Corporation plc | 165.54 Million USD | -32.359% |
| Mesoblast Limited | -9.81 Million USD | 2332.379% |
| Turnstone Biologics Corp. | 16.5 Million USD | -1227.445% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 298.308% |
| Synaptogenix, Inc. | -6347.00 USD | 3452250.622% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 429723.529% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -35.784% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 87.534% |
| Better Therapeutics, Inc. | -2.72 Million USD | 8128.875% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 295.351% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 35.191% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1920752.174% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 3600.128% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 19875.09% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -2894.096% |
| Insmed Incorporated | 239.63 Million USD | 8.566% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -6023.756% |
| OmniAb, Inc. | 14.66 Million USD | -1393.884% |
| Alector, Inc. | -95.05 Million USD | 330.511% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -74.42% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 604.125% |
| Zai Lab Limited | 170.9 Million USD | -28.206% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -167.606% |
| Aura Biosciences, Inc. | -1.29 Million USD | 17019.537% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -168444.615% |
| Immunic, Inc. | -111 Thousand USD | 197494.595% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -1282.036% |
| Veracyte, Inc. | 248.14 Million USD | 11.703% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 103.135% |
| FibroGen, Inc. | 128.9 Million USD | -69.978% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 38849036.17% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1978.033% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 93.553% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -56225.964% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 38.339% |
| Galecto, Inc. | -830 Thousand USD | 26498.554% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 15920.072% |
| Fortrea Holdings Inc. | 424 Million USD | 48.324% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 354.283% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 38743.386% |
| XBiotech Inc. | -1.74 Million USD | 12663.532% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 19875.09% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 571.494% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 390.079% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -198.5% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -1203.981% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 43.68% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 541.332% |
| Vaxxinity, Inc. | -2.23 Million USD | 9907.878% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 32.943% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 2034.926% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -796.111% |
| NexImmune, Inc. | -1.02 Million USD | 21476.974% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -4057455.556% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 3183.572% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.061% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 327973.464% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 6270.318% |
| Ainos, Inc. | -253.73 Thousand USD | 86453.766% |
| Pluri Inc. | 322 Thousand USD | -67945.963% |
| Prothena Corporation plc | -129.2 Million USD | 269.587% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -334.532% |
| Celularity Inc. | 6.75 Million USD | -3143.642% |
| Rallybio Corporation | -150 Thousand USD | 146172.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 771.966% |
| MeiraGTx Holdings plc | 287 Thousand USD | -76244.251% |
| Omeros Corporation | -69.77 Million USD | 414.003% |
| Humacyte, Inc. | -76.55 Million USD | 386.229% |
| Immunocore Holdings plc | 248.39 Million USD | 11.789% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1544.446% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -251.236% |
| Blueprint Medicines Corporation | 236.58 Million USD | 7.387% |
| CalciMedica, Inc. | -58 Thousand USD | 377872.414% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 15465.217% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -654.115% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 7804.219% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 809.891% |
| Pulmatrix, Inc. | -8.22 Million USD | 2765.547% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 18827.179% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 55014.286% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 154.943% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -7794.12% |
| Cytokinetics, Incorporated | -322.59 Million USD | 167.921% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -25315.466% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 64354.545% |
| Vor Biopharma Inc. | -3.49 Million USD | 6374.57% |
| Roivant Sciences Ltd. | 109.23 Million USD | -100.584% |
| Evogene Ltd. | 1.39 Million USD | -15561.758% |
| ProKidney Corp. | -3.16 Million USD | 7014.105% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 598.971% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -3095.392% |
| CorMedix Inc. | -205.56 Thousand USD | 106689.739% |
| BioLineRx Ltd. | 1.1 Million USD | -19675.09% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 378.512% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 664063.636% |
| Atai Life Sciences N.V. | -5000.00 USD | 4382260.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 179904.528% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 228337.5% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 15874.514% |
| Sagimet Biosciences Inc. | 2 Million USD | -10855.4% |
| MediciNova, Inc. | 979.7 Thousand USD | -22264.691% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 359.856% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 231825.451% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1157.432% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 10.398% |
| Biomea Fusion, Inc. | -4.2 Million USD | 5315.615% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 74.883% |
| Mereo BioPharma Group plc | 7.42 Million USD | -2850.552% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 70780.0% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1826000.0% |
| Absci Corporation | -41.84 Million USD | 623.568% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4382260.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 386.892% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 9003.21% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -2.514% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 23384.591% |
| Allakos Inc. | -6.14 Million USD | 3667.953% |
| Imunon, Inc. | -720 Thousand USD | 30531.455% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 417.566% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 53.959% |
| BioAtla, Inc. | -103.73 Million USD | 311.227% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1920752.174% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 123194.382% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 190.235% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 70552.733% |
| XOMA Corporation | 3.86 Million USD | -5574.903% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 412.632% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -1381.06% |
| aTyr Pharma, Inc. | -2.38 Million USD | 9275.377% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1658.491% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 755644.828% |
| Viridian Therapeutics, Inc. | -1 Million USD | 21836.905% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1685446053.846% |
| Akari Therapeutics, Plc | -4000.00 USD | 5477800.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 65.597% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -112431.586% |
| UroGen Pharma Ltd. | 73.35 Million USD | -198.708% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 920.814% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1887135.142% |
| Orgenesis Inc. | -5.72 Million USD | 3927.214% |
| Entera Bio Ltd. | -56 Thousand USD | 391364.286% |
| GH Research PLC | -315 Thousand USD | 69658.095% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 116030.159% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 41834.857% |
| Xencor, Inc. | -85.26 Million USD | 356.988% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 99254.211% |
| Replimune Group, Inc. | -2.65 Million USD | 8352.655% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 21983.752% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -23.202% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -112431.586% |
| Portage Biotech Inc. | -54 Thousand USD | 405855.556% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 231825.451% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 58218.833% |
| OncoCyte Corporation | 413 Thousand USD | -52952.785% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 4874582.759% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 98697397.297% |
| Purple Biotech Ltd. | -196 Thousand USD | 111889.796% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -2343.22% |
| scPharmaceuticals Inc. | 9.78 Million USD | -2139.91% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 2197.74% |
| HilleVax, Inc. | -2.15 Million USD | 10262.709% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 225984.536% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 1460430.579% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 32900.599% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 952743.478% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 2919142.493% |
| Savara Inc. | -44.26 Million USD | 595.025% |
| Curis, Inc. | 9.81 Million USD | -2133.289% |
| Daré Bioscience, Inc. | 2.76 Million USD | -7811.401% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 175684.191% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 12772.527% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 96200.0% |
| BeiGene, Ltd. | 2.07 Billion USD | 89.46% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 7936.761% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 154.823% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -286.516% |
| Erasca, Inc. | -3.73 Million USD | 5971.061% |
| bluebird bio, Inc. | -4.03 Million USD | 5536.923% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 776583.096% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 88.494% |
| DBV Technologies S.A. | 15.72 Million USD | -1293.108% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 776583.096% |
| Moderna, Inc. | 2.15 Billion USD | 89.833% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 24046.23% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -2636.797% |
| Molecular Templates, Inc. | 50.39 Million USD | -334.781% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 40978.358% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -63.773% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 3621.504% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 656.917% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 297.167% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 6206.689% |
| MacroGenics, Inc. | 50.52 Million USD | -333.645% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 3693.112% |
| Prime Medicine, Inc. | -147.9 Million USD | 248.141% |
| Aditxt, Inc. | -111.66 Thousand USD | 196327.834% |
| Adagene Inc. | 18.11 Million USD | -1109.773% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -44799.18% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -56.28% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -38.82% |
| SciSparc Ltd. | 2.19 Million USD | -9877.596% |
| Vericel Corporation | 135.57 Million USD | -61.613% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 874817.554% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 707310.638% |
| Generation Bio Co. | -73.91 Million USD | 396.448% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 50239.13% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -301.157% |
| Invivyd, Inc. | -2.02 Million USD | 10904.142% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 172.832% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 211925.441% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -127.366% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -122.924% |
| ADMA Biologics, Inc. | 88.21 Million USD | -148.371% |
| Clene Inc. | 533 Thousand USD | -41008.443% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -808.815% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 22995.298% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1157.432% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -10921.529% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 112858.599% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -339.932% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 3189.509% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 26309.091% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -162.672% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -299588.15% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -312.152% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 226.515% |
| Trevena, Inc. | 1.45 Million USD | -14958.969% |
| Surrozen, Inc. | -27.23 Million USD | 904.657% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 62170.255% |
| Cingulate Inc. | -582.91 Thousand USD | 37688.134% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 706900.0% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 1212.28% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 2894525.363% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 24970.375% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 67.812% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 22276.923% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 388989.283% |
| Kronos Bio, Inc. | 1.37 Million USD | -15869.971% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 508.281% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 75136.986% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 44970.309% |
| ImmunityBio, Inc. | -17.89 Million USD | 1324.751% |
| Korro Bio, Inc. | -3.63 Million USD | 6136.033% |
| Kineta, Inc. | 5.43 Million USD | -3932.91% |
| BioVie Inc. | -229.37 Thousand USD | 95623.091% |
| Codexis, Inc. | 57.33 Million USD | -282.161% |
| Celularity Inc. | 6.75 Million USD | -3143.642% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -5359.955% |
| Celcuity Inc. | -142.77 Thousand USD | 153567.066% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -433005.357% |
| Cibus, Inc. | 1.42 Million USD | -15308.439% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 58685.027% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1056.01% |
| IN8bio, Inc. | -2.5 Million USD | 8860.816% |
| Kodiak Sciences Inc. | -25.94 Million USD | 944.444% |
| Annexon, Inc. | -3.26 Million USD | 6806.703% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 10819.569% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 624.973% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -34135.625% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 71.856% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -26.685% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 11632.0% |
| Arcellx, Inc. | 108.27 Million USD | -102.355% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 776.907% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -176.638% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1135.874% |
| Moolec Science SA | -143.3 Thousand USD | 152996.27% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 617.765% |
| Geron Corporation | -123.5 Million USD | 277.411% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -6565.896% |
| Royalty Pharma plc | 1.79 Billion USD | 87.786% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 412.61% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 6066212.957% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -94591.669% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 296.661% |
| Humacyte, Inc. | -76.55 Million USD | 386.229% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 23184.071% |
| 89bio, Inc. | -273 Thousand USD | 80359.341% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 17531.026% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 25938.208% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 178236.585% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -19480.697% |
| Notable Labs, Ltd. | 113 Thousand USD | -193800.885% |
| Liquidia Corporation | 14.6 Million USD | -1400.74% |
| Mustang Bio, Inc. | -2.22 Million USD | 9947.551% |
| Immunovant, Inc. | -231 Thousand USD | 94951.948% |
| Quantum-Si incorporated | 488 Thousand USD | -44799.18% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 494.37% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 730460.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -11667.347% |
| Acasti Pharma Inc. | -11 Thousand USD | 1991990.909% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 107182.012% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 33889.29% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 230.801% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -19211.816% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 57608.661% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 11290.398% |
| PepGen Inc. | -1.18 Million USD | 18605.743% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 172625.984% |
| United Therapeutics Corporation | 2.07 Billion USD | 89.415% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1056.929% |
| Solid Biosciences Inc. | -76.56 Million USD | 386.18% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 265418.528% |
| Immuneering Corporation | -764.13 Thousand USD | 28773.878% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -330559.181% |
| Belite Bio, Inc | -399 Thousand USD | 55014.286% |
| XOMA Corporation | 3.86 Million USD | -5574.903% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 1193.572% |
| Bionomics Limited | -434.44 Thousand USD | 50533.538% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 20501.117% |
| uniQure N.V. | 2.21 Million USD | -9792.009% |
| Cassava Sciences, Inc. | -89.42 Million USD | 345.024% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 337.982% |
| Forte Biosciences, Inc. | -9000.00 USD | 2434633.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 26340.479% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 50239.13% |
| Altimmune, Inc. | -65.37 Million USD | 435.166% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 39.478% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 20501.117% |
| Compugen Ltd. | 31.45 Million USD | -596.576% |
| Peak Bio, Inc. | 367.76 Thousand USD | -59477.615% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -793.735% |
| Benitec Biopharma Inc. | 108 Thousand USD | -202777.778% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 281007.692% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 18313.466% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 12125.686% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 184224.37% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 18313.466% |
| Instil Bio, Inc. | -4.75 Million USD | 4706.981% |
| argenx SE | 1.1 Billion USD | 80.233% |
| Immunome, Inc. | -8.9 Million USD | 2559.953% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 11693.016% |
| Verona Pharma plc | -679.62 Thousand USD | 32339.591% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 125304.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 9286.918% |
| CervoMed Inc. | -1.29 Million USD | 17037.494% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 9202.95% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 4686.728% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -8767.179% |
| Moolec Science SA | -143.3 Thousand USD | 152996.27% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 53798.993% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 8301.598% |
| AnaptysBio, Inc. | 14.78 Million USD | -1382.362% |
| Design Therapeutics, Inc. | -537 Thousand USD | 40902.235% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 51413.349% |
| NeurAxis, Inc. | 2.15 Million USD | -10059.391% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -10110.065% |
| Lumos Pharma, Inc. | 2 Million USD | -10817.19% |
| Achilles Therapeutics plc | -4.73 Million USD | 4731.064% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 125304.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 207441.377% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -592.093% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -25315.466% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 21331.395% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 581.049% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -509453.488% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 26755.474% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1665307.478% |
| Palisade Bio, Inc. | 246 Thousand USD | -88968.293% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 664063.636% |
| Beam Therapeutics Inc. | -59.67 Million USD | 467.187% |
| Neurogene Inc. | -3.26 Million USD | 6816.983% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -57.253% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 6034.67% |
| Sesen Bio, Inc. | 40 Million USD | -447.77% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 73873.737% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 5540.923% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 2390.487% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -1456.165% |
| Athira Pharma, Inc. | -969 Thousand USD | 22711.765% |
| Vaccinex, Inc. | -16 Million USD | 1469.083% |
| HCW Biologics Inc. | -574.82 Thousand USD | 38217.406% |
| XOMA Corporation | 3.86 Million USD | -5574.903% |
| Nektar Therapeutics | 53.47 Million USD | -309.716% |
| Arvinas, Inc. | 71.8 Million USD | -205.164% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 362.527% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 449.037% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 68145.963% |
| Rezolute, Inc. | -36 Thousand USD | 608733.333% |
| Clene Inc. | 533 Thousand USD | -41008.443% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 17064585.981% |
| BeyondSpring Inc. | 1.75 Million USD | -12413.307% |
| Synlogic, Inc. | -1.92 Million USD | 11488.15% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 592283.784% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 3560.328% |
| Peak Bio, Inc. | 367.76 Thousand USD | -59477.615% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 1255.45% |
| Krystal Biotech, Inc. | 47.6 Million USD | -360.263% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -55.296% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -4260.358% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 8562.32% |
| MannKind Corporation | 136.19 Million USD | -60.883% |
| Ikena Oncology, Inc. | -50.49 Million USD | 533.946% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -101.36% |
| Gossamer Bio, Inc. | -4.38 Million USD | 5096.762% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 87047.619% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 4382260.0% |
| Legend Biotech Corporation | 140.92 Million USD | -55.474% |
| Mural Oncology plc | -2.56 Million USD | 8635.567% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 39865.517% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 219208.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -955.739% |
| REGENXBIO Inc. | 53.02 Million USD | -313.185% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 4190.161% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 113996.296% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 12750.577% |
| Vaxart, Inc. | -60.76 Million USD | 460.594% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 83480.775% |
| Cellectis S.A. | 18 Thousand USD | -1217166.667% |
| Longeveron Inc. | 221 Thousand USD | -99043.891% |
| Repare Therapeutics Inc. | -80.07 Million USD | 373.646% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 79.953% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 17032.612% |
| Revolution Medicines, Inc. | -399.66 Million USD | 154.823% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 626122.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -447059.184% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 97.454% |
| Denali Therapeutics Inc. | -93.34 Million USD | 334.729% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 874817.554% |
| Veru Inc. | 7.56 Million USD | -2795.983% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 145204.636% |
| Cingulate Inc. | -582.91 Thousand USD | 37688.134% |
| Passage Bio, Inc. | -3.72 Million USD | 5988.417% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1819329.492% |
| Exicure, Inc. | -1.42 Million USD | 15497.611% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 57308.355% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -8006.104% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 42838.187% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -221.622% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 146555.714% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 470.077% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -55937.852% |
| OmniAb, Inc. | 14.66 Million USD | -1393.884% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -995.924% |
| Lipocine Inc. | -2.85 Million USD | 7785.794% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 11988.66% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 3940.631% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 14646.193% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -190.918% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 337189.231% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -159.927% |
| Ocugen, Inc. | -33.53 Million USD | 753.332% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 7029.412% |
| Q32 Bio Inc. | 578 Thousand USD | -37807.958% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 82782.264% |
| Alumis Inc. Common Stock | -1.28 Million USD | 17164.486% |
| Equillium, Inc. | 35.95 Million USD | -509.344% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 12935.852% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -43662.171% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 5300245.138% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 84697.683% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -51733.873% |
| Dominari Holdings Inc. | 2.03 Million USD | -10645.856% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 119523.778% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1711.681% |
| Bio-Techne Corporation | 773.07 Million USD | 71.658% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -1165.131% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 52.449% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 18843.199% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1013.711% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1773.198% |
| Nkarta, Inc. | -5.86 Million USD | 3833.311% |
| BioCardia, Inc. | -7.24 Million USD | 3122.596% |
| Iterum Therapeutics plc | -1.75 Million USD | 12620.457% |